By understanding the risks, staying hydrated, and working closely with a provider to personalize your dosage, you can effectively manage your weight without compromising your gut health
Frontiers in Psychiatry, 8 , 80
ACHIEVE-3 was the head-to-head trial against oral semaglutide in T2D (1,698 patients, 52 weeks), showing orforglipron superiority
Along with not overbuying ingredients (hooray for minimizing food waste), I know Im getting something wholesome, plus the meals are affordable
Image Credit: Love Employee / Shutterstock In a recent study published in the International Journal of Obesity , researchers assessed the effects of glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) agonists on weight and body composition in adults with overweight or obesity
In SURMOUNT-1 (NEJM 2022, 2,539 adults with obesity), the 15 mg arm averaged 22.5% body weight loss at 72 weeks, the 10 mg arm 21.4%, and the 5 mg arm 16.0%